Document Detail


Inhibition of endogenous ganglioside synthesis does not block neurite formation by retinoic acid-treated neuroblastoma cells.
MedLine Citation:
PMID:  8995443     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Gangliosides are believed to play a critical role in cellular differentiation. To test this concept, we determined the effect of inhibition of endogenous ganglioside synthesis upon neurite formation induced by retinoic acid in LAN-5 human neuroblastoma cells. Ganglioside synthesis and content of LAN-5 cells exposed for 6 days to 10 microM D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (D-PDMP) (an inhibitor of glucosylceramide synthase) were reduced by >90%. However, these ganglioside-depleted cells were not blocked from forming neurites when exposed to 10 microM retinoic acid. Even more extensive treatment of LAN-5 cells with 20 microM D-PDMP (6 day pretreatment followed by 6 days together with 10 microM retinoic acid) still did not block the retinoic acid-induced neurite formation. An element of neuroblastoma tumor cell differentiation, neurite formation, is therefore dependent neither on an intact cellular ganglioside complement nor on new ganglioside synthesis.
Authors:
R Li; S Ladisch
Related Documents :
17597153 - Formation of amyloids by abeta-(1-42) on ngf-differentiated pc12 cells: roles of gangli...
12424733 - Role of c-jun concentration in neuronal cell death.
23497233 - Stochastic time-concentration activity models for in vitro neurotoxicity.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Journal of biological chemistry     Volume:  272     ISSN:  0021-9258     ISO Abbreviation:  J. Biol. Chem.     Publication Date:  1997 Jan 
Date Detail:
Created Date:  1997-02-12     Completed Date:  1997-02-12     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  2985121R     Medline TA:  J Biol Chem     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1349-54     Citation Subset:  IM    
Affiliation:
Center for Cancer and Transplantation Biology, Children's Research Institute, Washington, D.C. 20010, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Down-Regulation
Enzyme Inhibitors / pharmacology
Gangliosides / biosynthesis*
Glucosyltransferases / antagonists & inhibitors
Humans
Morpholines / pharmacology
Neurites / metabolism*
Neuroblastoma / metabolism*
Tretinoin / pharmacology*
Tumor Cells, Cultured
Grant Support
ID/Acronym/Agency:
CA42361/CA/NCI NIH HHS; CA61010/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Enzyme Inhibitors; 0/Gangliosides; 0/Morpholines; 302-79-4/Tretinoin; 73257-80-4/RV 538; EC 2.4.1.-/Glucosyltransferases; EC 2.4.1.80/ceramide glucosyltransferase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Endoprotease activities other than furin and PACE4 with a role in processing of HIV-I gp160 glycopro...
Next Document:  Chk, a Csk family tyrosine protein kinase, exhibits Csk-like activity in fibroblasts, but not in an ...